Investors responded well to Ami Organics and Vijaya Diagnostics Centre’s IPOs, which were both announced earlier this week. Ami Organics IPO received 64.54 times subscription on the final day, while the Vijaya Diagnostics IPO received 4.54 times subscription, according to BSE data.
According to BSE data, the Ami Organics IPO got bids for around 42.22 crores (42,22,36,296) shares out of a total issue size of 65.42 lakh (65,42,342) shares.
The share allotment for Ami Organics’ Rs 570-crore IPO, which was subscribed 64.54 times, will be completed on September 8, 2021.
Ami Organics will join Aarti Industries, Hikal, Valiant Organics, Vinati Organics, Neuland Organics, and Atul Ltd as listed industry peers when it goes public.
Ami Organics shares were spotted trading at a premium of Rs 165 to the IPO price of Rs 610 per share in the primary market.
The shares designated for qualified institutional buyers (QIBs) were subscribed 86.64 times, while non-institutional investors were subscribed 154.81 times and retail individual investors (RIIs) were subscribed 13.36 times, according to the data.
Ami Organics’ Rs 570 crore IPO began on September 1, 2021, and ended at 5 p.m on September 3.
It had a price range of Rs 603-610 per share, and the company raised approximately Rs 171 crore (Rs 1,70,89,05,850) from 20 anchor investors in exchange for 28,01,485 equity shares at Rs 610 apiece before going public.
According to persons who deal in shares of unlisted companies, Ami Organics shares were trading at Rs 775 in the grey market, a premium of 27% over the issue price.
On September 9, refunds or unblocking of cash from the ASBA account will begin, and equity shares will be paid to allottees’ bank accounts on September 13.
The shares are expected to go public on September 14, 2021. Investor sentiment is weak, according to analysts, following the recent upheaval in main markets. Ami Organics, on the other hand, had a positive response from investors.
“Due to its moderate pricing, we may witness reasonable listing gains on its debut. Strong product portfolio and dominating market share may attract investors to bet for the long term,” Abhay Doshi, Founder, UnlistedArena.com, dealing in Pre-IPO & Unlisted Shares, told Financial Express Online.
According to stock exchange data, the IPO of pathology and radiology testing company Vijaya Diagnostic Centre got bids for over 11.36 crore (11,36,44,020) shares against total issue size of over 2.50 crore (2,50,26,646) shares.
The shares reserved for qualified institutional buyers (QIBs) were subscribed 13.07 times, while non-institutional investors were subscribed 1.32 times, and retail individual investors (RIIs) were subscribed 1.09 times.
According to the data, shares for the employees’ segment were subscribed 0.98 times.
The pathology and radiology test provider’s Rs 1,895 crore IPO began on September 1, 2021, and ended today. Vijaya Diagnostic Centre received about Rs 566 crore (Rs 5,66,12,12,958) from 41 anchor investors in lieu of 1,06,61,418 equity shares at Rs 531 apiece before launching its initial public offering.
Investors will now be anticipating the share allotment dates for both transactions. According to the information supplied in both firms’ red herring prospectuses, the finalisation of the basis of allocation for both Ami Organics and Vijaya Diagnostics Centre is planned to take place on Wednesday, September 8, 2021.
